Hrt Financial LP Surface Oncology, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.45 - $9.09 $1.06 Million - $1.49 Million	-163,968 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.25 - $13.82 $122,003 - $232,562	16,828 Added 11.44%	163,968 $1.28 Million
Q4 2020 Feb 16, 2021	BUY	$6.87 - $10.48 $1.01 Million - $1.54 Million	147,140 New	147,140 $1.36 Million
Q1 2020 May 15, 2020	SELL	$1.44 - $3.95 $28,725 - $78,794	-19,948 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.17 - $2.33 $23,339 - $46,478	19,948 New	19,948 $37,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.